Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the Citigroup 2013 Global Healthcare Conference at the Hilton New York Hotel on Monday, February 25, 2013. Michael A. Mussallem, Edwards Lifesciences' chairman and chief executive officer, is scheduled to speak to conference attendees at 8:45 a.m. EST. Mussallem is also scheduled to speak at the RBC Capital Markets Global Healthcare Conference at the New York Palace Hotel on Tuesday, February 26, 2013, at 3:05 p.m. EST.
Live webcasts of both presentations will be available to all interested parties on the Edwards Lifesciences investor relations website at http://ir.edwards.com. Following each presentation, an archived version of the webcast will be available on the Edwards investor relations website in the News and Events section and via the Edwards Lifesciences Investor Relations App for mobile devices.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.
David K. Erickson
Edwards Lifesciences Corporation
One Edwards Way
Irvine, CA USA 92614
© 2017 Canjex Publishing Ltd. All rights reserved.